Precision Digital Therapeutics for Mental Health

Personalized Digital Therapeutic programs based on objective measurement and data.

Data-Driven DTx for MDD & GAD

Feel DTx is the world’s first data-driven digital therapeutic program for the personalized treatment of depression and anxiety.

What does it include

Feel DTx, designed as an adjunct to care for MDD and GAD, teaches patients new skills and behaviors to empower them to self-manage their anxiety and depression, while providing real-time interventions and a dedicated health coach. The DTx is accessible via smartphone devices.

Data-Driven Real-Time Interventions

A smartphone app that provides real-time support and evidence-based interventions (i.e. mood journaling, emotion regulating techniques, cognitive restructuring exercises etc.).

​Behavioral Health Coach

45-minute introductory session and weekly 15-minute remote data-driven sessions with a dedicated Board-Certified Health Coach trained in behaviour change.

16-week Digital CBT Program

Structured program based on CBT with weekly material and exercises meant to enhance knowledge, awareness of body-mind connection, cognitive restructuring, and build skills to increase resilience and long-term positive habits.

Feel Emotion Sensor

A wristband with integrated biosensors that continuously monitors a variety of physiological signals to extract metrics and insights related to the mental health of an individual with the goal to increase engagement.

*The use of the Feel Emotion Sensor is optional

Results

Feel DTx is offering digital cognitive behavioral therapy (CBT) to reduce symptoms of MDD and GAD. By providing cognitive restructuring and emotion regulating interventions, the program enables individuals to self-manage their thoughts, feelings, and behaviors.

54%

Depression decrease
(PHQ-9)

55%

Anxiety decrease
(GAD-7)

15%

Quality of life increase

24%

Life satisfaction increase

94%

of participants demonstrated improvement in mental health outcomes

Eligibility

Feel DTx is a digital therapeutic intended for adults in the U.S. 18 years or older who are experiencing Major Depressive Disorder (MDD) or Generalized Anxiety Disorder (GAD).
Read our safety information.

Additional information

Pipeline

Digital Therapeutics & Programs and for Mental Health

Research

Design & POC

Clinical studies

Regulatory

Commercial launch

01.

Depression (MDD)

02.

Anxiety (GAD)

03.

ADHD

04.

MULTIPLE SCLEROSIS

05.

INSOMNIA

06.

Breast Cancer

Gain early access

Do you want to participate in Feel's Digital Therapeutics for Depression and Anxiety Clinical Trial?

Apply now

Contact us

Learn more about Feel, request a demo or discuss your project!  Fill in the form below or send us an email at  info@myfeel.co

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.